FindTrial
Sign In

Effect of Ashtamangal ghrita in autism

To Evaluate The Efficacy Of Ashtamangal Ghrita In Management Of Autism In Children - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094139
Enrollment
30
Registered
2025-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F949- Childhood disorder of social functioning, unspecified

Interventions

None listed

Sponsors

Rishikul Campus
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 5 to 10 years,Patients satisfying Indian Scale for Assessment of Autism (ISAA) criteria

Exclusion criteria

Exclusion criteria: Patients before 5 years and after 10 years of age, Taking ASD medicine from any other system, Presence of other organic or psychotic neurological disorders, Patients with Developmental disorders along with hearing and visual impairments, Known cases of congenital disorders, Genetic disorders like fragile X Syndrome, Turner?s Syndrome, etc.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Ashtamangal ghrita in management of autism Subjectively all sign and symptoms are given with grading depending in their severityTimepoint: 15 days—

Secondary

MeasureTime frame
o evaluate the efficacy of Ashtamangal ghrita in management of autism Subjectively all sign & symptoms are given with gradings depending on their severityTimepoint: Fifteen days—

Countries

India

Contacts

Public ContactDr Keerti Verma

Rishikul Campus, Haridwar

keerti.vrm@gmail.com9997777833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026